Transchem

Transchem EBIT per Share

The EBIT per Share of Transchem (500422.BO) as of Oct 21, 2026 is -2.93 INR. In the previous year, EBIT per Share was -1.20 INR — a change of 143.88% (lower).

EBIT per Share

-2.93INR

YoY

143.88%

Last updated:

EBIT per Share of Transchem is 2026 -2.93 INR. EBIT per Share of Transchem was 2025 -1.20 INR. It decreases by 143.88% lower compared to the previous year.

The Transchem EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2018
-2.17 INR
Jan 1, 2019
-1.76 INR
Jan 1, 2020
-1.61 INR
Jan 1, 2022
-2.25 INR
Jan 1, 2023
2.05 INR
Jan 1, 2024
-1.41 INR
Jan 1, 2025
-1.20 INR
Jan 1, 2026
-2.93 INR
The Transchem EBIT per Share history
YEAREBIT per ShareYoY
-2.93INR+143.88%
-1.20INR-14.64%
-1.41INR-168.74%
2.05INR-191.01%
-2.25INR+39.93%
-1.61INR-8.56%
-1.76INR-19.16%
-2.17INR+32.84%
-1.64INR+4.36%
-1.57INR+3.49%
-1.52INR-27.66%
-2.09INR-6.40%
-2.24INR+16.67%
-1.92INR-47.30%
-3.64INR-8.26%
-3.97INR+23.79%
-3.20INR+110.22%
-1.52INR-589.47%
0.31INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Transchem Stock analysis

What does Transchem do? Transchem Ltd is a pharmaceutical company based in Thane, India, operating within the Health Care sector. The company has been publicly traded since its IPO on January 27, 1993, with a ticker symbol of 500422.BO and ISIN code INE019B01010. Its headquarters are located in Thane, Maharashtra. Transchem Ltd is engaged in the production and processing of pharmaceutical products, though specific product details are not provided. The company's website is https://www.transchem.net/. While the source description mentions the company's involvement in mushroom production, this appears to be an unverified or incorrect detail, as the company is classified under the Pharmaceuticals industry. The source also states that the company temporarily invests funds in short-term treasury operations while seeking new business opportunities, but this information should be treated with caution as it is not confirmed by official company sources. The company's primary focus remains on pharmaceutical manufacturing and processing within the Indian market. No additional details about its founding year, key personnel, acquisitions, or financial figures are provided in the available information. Transchem Ltd operates as a publicly listed entity on the Bombay Stock Exchange, though specific market capitalization or trading volume data is not included in the given facts. The company's activities are centered around pharmaceutical production, with no indication of other significant business lines beyond those related to the Health Care sector. Transchem is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Transchem stock

EBIT per Share of Transchem is -2.93 INR in 2026.

EBIT per Share of Transchem changed from -1.20 INR to -2.93 INR, representing a 143.88% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Transchem since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Transchem

All Key Metrics — Transchem